Riskpilot← Back to searchSign inGet full accessLIMBRA AS
ASActiveOrg 999276938Solakrossen 11, 4050 SolaOther human health activities n.e.c. · NACE 8699Est. 201311 employees
Revenue 2024
NOK 29,7M
+57% vs 2023
EBITDA margin
-13.4%
-55% vs 2023
Equity ratio
25.1%
Financial strength
Net profit 2024
NOK -5M
-36% vs 2023
| Revenue | NOK 29,7M | +57% |
| EBITDA | NOK -4M | -55% |
| Net profit | NOK -5M | -36% |
| Total assets | NOK 368,6M | +15% |
| Equity | NOK 92,5M | -5% |
| Employees | 11 | — |
Legal name
LIMBRA AS
Org number
999276938
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
17. januar 2013
Share capital
NOK 3 924 971
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Drive virksomhet med hovedvekt på eierskap, forvaltning og drift av helseklinikker, samt annen virksomhet som står i naturlig sammenheng med dette.
Address
Solakrossen 11, 4050 Sola
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 587 | 13 413 | 12 161 | 12 764 | 15 155 | 16 905 | 14 074 | 0 | 0 | 18 949 | 29 710 |
| Staff expenses | −5 837 | −5 847 | −8 565 | −8 742 | −9 147 | −8 260 | −6 318 | −12 663 | −13 825 | −11 143 | −16 528 |
| EBITDA | −3 638 | −1 392 | −6 459 | −7 931 | −8 706 | −7 845 | −2 930 | −21 219 | −22 805 | −2 561 | −3 983 |
| Depreciation & amort. | −130 | −99 | −117 | −153 | −153 | −154 | −239 | −782 | −1 087 | −952 | −1 055 |
| EBIT | −3 767 | −1 492 | −6 576 | −8 083 | −8 859 | −8 000 | −3 169 | −22 001 | −23 892 | −3 514 | −5 037 |
| Net financials | 3 776 | 1 731 | 6 923 | 8 503 | 11 653 | 10 996 | 7 169 | 8 429 | 3 808 | −1 225 | −1 386 |
| Profit before tax | 8 | 239 | 347 | 420 | 2 794 | 2 996 | 3 999 | −13 572 | −20 084 | −4 738 | −6 424 |
| Tax | 5 | −0 | 26 | −0 | −0 | 846 | 962 | −2 983 | −4 418 | −1 041 | −1 409 |
| Net profit | 3 | −1 222 | 321 | −5 061 | 3 521 | 2 150 | 3 038 | −10 589 | −15 665 | −3 697 | −5 015 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 94 629 | 110 067 | 110 095 | 137 846 | 159 069 | 198 613 | 235 057 | 250 075 | 333 807 | 320 483 | 368 551 |
| Equity | 64 586 | 64 914 | 66 376 | 68 198 | 66 663 | 83 561 | 127 438 | 116 849 | 101 183 | 97 486 | 92 471 |
| Long-term debt | 9 762 | 12 011 | 6 703 | 18 045 | 20 110 | 15 635 | 101 142 | 103 055 | 200 534 | 152 614 | 171 155 |
| Short-term debt | 20 281 | 33 142 | 37 016 | 51 603 | 72 296 | 99 418 | 6 477 | 30 171 | 32 090 | 70 383 | 104 925 |
| Total debt | 30 043 | 45 153 | 43 719 | 69 648 | 92 407 | 115 053 | 107 619 | 133 226 | 232 624 | 222 997 | 276 080 |
EBITDA margin
-13.4%
This company
15.8%
Market median
-185% vs market
20142024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
20142024
Return on equity
-5.4%
This company
18.4%
Market median
-129% vs market
20142024
Net profit margin
-16.9%
This company
8.1%
Market median
-309% vs market
20142024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20142024
Debt / equity
2.99×
This company
0.62×
Market median
-382% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
JJ Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Physical Medicine Holding As | Company | 96.0% | 96.0% | 2024 |
Physical Medicine Group As | Company | 4.0% | 4.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Physical Medicine Holding As
LIMBRA AS Board members of LIMBRA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Magnus Lagerkvist | Chief Executive Officer | 0 companies |
| Jan Jesper Albin Ask | Chief Executive Officer | 0 companies |
| Torleiv Broch-Austvoll | Board of Directors | 0 companies |
| Oscar Maaseide | Chairman | 0 companies |
| Mats Karl Johan Gunnarsson | Board of Directors | 0 companies |
| Gunnar Andreas Göthberg | Chairman | 0 companies |